Distal hereditary motor neuropathy type V
Distal hereditary motor neuropathy type V (dHMN V) is a rare genetic disorder that primarily affects the motor neurons in the peripheral nervous system. This condition is characterized by progressive muscle weakness and atrophy, particularly in the distal parts of the limbs, such as the hands and feet.
Clinical Features[edit | edit source]
Individuals with dHMN V typically present with symptoms in late childhood or early adulthood. The primary clinical features include:
- Progressive muscle weakness and atrophy in the hands and feet
- Difficulty with fine motor skills, such as buttoning clothes or writing
- Foot deformities, such as pes cavus (high-arched feet)
- Mild to moderate sensory loss in the affected areas
Genetics[edit | edit source]
dHMN V is inherited in an autosomal dominant manner. Mutations in the BSCL2 gene have been identified as a cause of this condition. The BSCL2 gene provides instructions for making a protein called seipin, which is involved in the development and maintenance of motor neurons.
Diagnosis[edit | edit source]
The diagnosis of dHMN V is based on clinical evaluation, family history, and genetic testing. Electromyography (EMG) and nerve conduction studies (NCS) are often used to assess the function of the peripheral nerves and muscles.
Differential Diagnosis[edit | edit source]
dHMN V should be differentiated from other types of hereditary motor neuropathies, such as:
- Charcot-Marie-Tooth disease
- Spinal muscular atrophy
- Other subtypes of distal hereditary motor neuropathy
Management[edit | edit source]
There is currently no cure for dHMN V. Management focuses on symptomatic treatment and supportive care, including:
- Physical therapy to maintain muscle strength and flexibility
- Occupational therapy to assist with daily activities
- Orthopedic interventions for foot deformities
- Pain management, if necessary
Prognosis[edit | edit source]
The progression of dHMN V is typically slow, and life expectancy is generally not affected. However, the degree of disability can vary widely among affected individuals.
See Also[edit | edit source]
References[edit | edit source]
-
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD